Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Capital Expenditures (2023 - 2025)

Fractyl Health's Capital Expenditures history spans 3 years, with the latest figure at $3000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 98.71% year-over-year to $3000.0, compared with a TTM value of $557000.0 through Dec 2025, down 68.44%, and an annual FY2025 reading of $557000.0, down 68.44% over the prior year.
  • Capital Expenditures for Q4 2025 was $3000.0 at Fractyl Health, down from $8000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $1.3 million in Q3 2024, with the low at -$859000.0 in Q2 2024.
  • Average Capital Expenditures over 3 years is $201083.3, with a median of $76500.0 recorded in 2023.
  • Biggest YoY gain for Capital Expenditures was 5195.0% in 2024; the steepest drop was 1661.82% in 2024.
  • Tracing GUTS's Capital Expenditures over 3 years: stood at -$132000.0 in 2023, then skyrocketed by 276.52% to $233000.0 in 2024, then tumbled by 98.71% to $3000.0 in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Capital Expenditures are $3000.0 (Q4 2025), $8000.0 (Q3 2025), and $98000.0 (Q2 2025).